Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials
Future Oncology - United Kingdom
doi 10.2217/fon-2019-0373
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2019
Authors
Publisher
Future Medicine Ltd